
The Pathology Facilities and Operations team manages facilities, equipment, and safety and compliance for the Department across multiple sites – Westwood, the Bruin University Reference Laboratory (BURL), Santa Monica Medical Center, The UCLA Immunogenetics Center (UIC), Olympic Analytical Lab (OAL) and West Valley Medical Center (WVMC).
The Pathology Facilities and Operations team is comprised of three specialty groups: Pathology Facilities, Pathology Equipment, and Pathology Safety & Compliance. The groups work seamlessly together to maintain operations and execute high-level projects across our multiple locations. They are also a key component for successful department events, ensuring appropriate A/V and technical support and event management. They have supported large-scale events including Research Day and department appreciation events.
The Facilities teams manages Pathology-owned spaces and laboratories, including key/badge access, office/workstation installs, vendor management, furniture procurement, and partnering with University Facilities to address issues/damage requiring work by teams outside of the department.
Pathology Equipment manages department equipment and maintenance, not limited to microscopes, computers, conference rooms, and other required equipment. They also assist with requests for equipment relocation, software requests, and interfaces with ISS and DGIT for seamless workstation installations.
Pathology Safety & Compliance assists with pre-inspection and inspection requests, reporting for Chemical/Biohazardous Spills (post-event), Reporting Accidents (post-incident, research-side only), Laboratory Onboarding/Decommission, Emergency Preparedness, capital lab equipment requests, training, and general safety practices.
The Pathology Facilities and Operations team is a vital part for the Department of Pathology and Laboratory Medicine. They provide essential resources to ensure maximum efficiency within our facilities to foster a safe and productive environment to further our Department’s commitment and UCLA Health’s mission to deliver leading-edge patient care, research, education, and community engagement. Thank you Facilities and Operations team, for all you do to help our Department provide outstanding patient care, research, education and administrative activities!!!









You may have noticed you have not seen Lindy Coe, Facilities and Operations and Pathology Administrative Services Manager for Pathology & Laboratory Medicine, on site recently. This is because Lindy has embraced a new and profoundly special project: motherhood. We are thrilled to share that Lindy and her husband, Garth, welcomed their beautiful daughter, Poppy Maureen Coe, into the world on March 20th—two weeks ahead of schedule, eager to meet her loving family.
Lindy has been a cornerstone of our operations, guiding her teams with dedication and expertise. From overseeing vital Facilities projects to deftly managing unforeseen faculty needs, her contributions have been nothing short of exceptional.
Please join me in extending heartfelt congratulations to Lindy and Garth as they embark on this joyous new chapter with baby Poppy.


Residency Program Director – Dr. Zhen Mei
I am pleased to announce Dr. Zhen Mei will be assuming the role of Residency Program Director beginning July 1, 2025. Dr. Jonathan Zuckerman will serve as the Residency Program Senior Advisor over the next year to ensure a smooth transition as he focuses on expanding his renal pathology commitments.
Dr. Mei has a long-standing passion for education. He has been serving as our Associate Residency Program Director for CP since 2021. He completed his residency at the University of Chicago, followed by a Transfusion Medicine fellowship at UCLA. He is passionate about education and since joining the UCLA faculty, has created a new coagulation curriculum for the residents, served on both the Phase 1 and Phase 2 Curriculum Revision Committees, participated in the Pathology Interest Group and was one of the Specialty Advisors for Career Exploration in Pathology for the DGSOM medical students.
His institutional knowledge and passion for medical education will serve him well in this role.
Dr. Mei will be stepping down from his role as the Associate Residency Program Director, CP as of July 1, 2025. The Department was thrilled to receive many strong applications for new Associate Residency Program Directors and we anticipate announcing the new APDs soon.
I would like to thank Dr. Zuckerman for all his hard work, dedication, and commitment to resident education over the past three years. He has been a passionate and committed voice for resident educational needs since his days as a Chief Resident and we all are grateful for his efforts and service.

Our amazing PA team includes:
Leadership
Santa Monica
Westwood
PA Students



DNA Day – April 25, 2025
Since the completion of the Human Genome Project in 2003, which coincided with the 50th anniversary of the discovery by Watson and Crick of the structure of DNA, the date of April 25th has been designated worldwide as "DNA Day." (Their one-page paper was published in the April 25, 1953 issue of Nature.)
In honor of DNA Day, Dr. Wayne Grody hosted a celebratory event offering a screening of a wonderful 1986 British film Race for the Double Helix (starring Jeff Goldblum as James Watson). Despite its high quality, access to this film is very rare, as it has never been issued on VHS or DVD (in the US, it was broadcast once on the A&E Network). Dr. Grody was able to obtain a digital copy and shared the movie with the Molecular Diagnostic Laboratory group to celebrate DNA Day.
Thank you Dr. Grody for this wonderful event!


















PLUGS Summit – Seattle, WA
Congratulations to Dr. Allison Chambliss, Dr. Khalda Ibrahim, Charlemagne (Carlo) Isip, William Werre, and Dr. Alyssa Ziman on winning the Best Abstract Award at PLUGS Summit with their abstract "Electronic Health Record Integration of Referral Lab Requisition Forms Reduces Clerical Errors and Delays."
The PLUGS Summit was held from April 2-April 4, 2025 in Seattle, WA. PLUGS (Patient-centered Laboratory Utilization Guidance Services) is a laboratory stewardship collaborative with a mission to improve laboratory test access, ordering, retrieval, interpretation and reimbursement.






American Board of Pathology – Pediatric Pathology Test Development and Advisory Committee Annual Meeting
The Pediatric Pathology Test Development and Advisory Committee (TDAC) meets annually and writes and reviews pediatric, perinatal, and placental pathology questions for the subspecialty board examination. TDAC also designates pediatric questions that may also be appropriate for inclusion on the anatomic and clinical pathology examinations. TDAC provides guidance on the content specification document for pediatric pathology and participates in the periodic modified Angoff standard setting to determine the pass-point for the examination. Dr. Jeffrey Goldstein has been a member of the committee since 2005 and has chaired the committee as an ABPath Trustee since 2015.
Pictures courtesy of the American Board of Pathology on X

The Molecular Diagnostics Laboratories (MDL) successfully launched the 221-gene Hematological Malignancy DNA sequencing Panel test on March 17, 2025. The 221-gene panel test replaced the 54-gene panel test in use since 2016. The new panel enables a high-volume hematological malignancy test to be performed in house with better turn-around-time, as well as provides up-to-date comprehensive molecular results for diagnosis, prognosis, and treatment to improve patient care.
The successful development of the new test was a collaborative effort from various specialty areas of the MDL group. Key contributors are shown below.

(Back Row L to R): Dr. Xiavan Roopnarinesingh, Thien, Dr. Dinesh Rao, Ian, Dr. Manando Nakasaki
(Middle Row L to R): Dr. Layal Abi Farraj, Dr. Anamaria Munteanu, Yan, Dr. Kajia Cao, Dr. Sheeja Pullarkat, Annabella
(Front Row L to R): Dr. Lily Zhang, Dr. Helen Jin, Svetlana
Not Shown: Dr. Niroshi Senaratne and Dr. Diana Golden
Dr. Jennifer Chia was spotlighted by the Broad Stem Cell Research Center in a YouTube video on Improving Blood Cell Production as We Age. Dr. Chia is investigating why our bodies produce fewer blood cells as we age — a reality that makes us more vulnerable to infections and blood cancers.






The below photo captures (left to right) Dr. Kene Ojukwu (Faculty), Dr. Precious Fortes (Cytopathology Fellow), Dr. Trang Lollie (Former Chief Resident), and Dr. Carlos Casiano (Former Chief Resident) attending the USCAP in Boston.
Please send your captions to Anastasia (agustafson@mednet.ucla.edu) by Monday, May 12, 2025 for a chance to win a prize! One entry per person.